BIOGEN INC. Noncontrolling Interest, Decrease from Deconsolidation
BIOGEN INC. (BIIB) reported Noncontrolling Interest, Decrease from Deconsolidation of $7.50 million for the 12-month period ending 2016-12-31, per its 10-K filed 2019-02-06.
Discontinued › Shareholders' Equity › Noncontrolling Interest Items
us-gaap:NoncontrollingInterestDecreaseFromDeconsolidation · last filed 2019-02-06
- BIOGEN INC. noncontrolling interest, decrease from deconsolidation for the quarter ending 2014-09-30 was $0.00.
- BIOGEN INC. noncontrolling interest, decrease from deconsolidation for the quarter ending 2014-06-30 was $0.00.
- BIOGEN INC. noncontrolling interest, decrease from deconsolidation for the quarter ending 2014-03-31 was $0.00, a 100.00% decline year-over-year.
- BIOGEN INC. noncontrolling interest, decrease from deconsolidation for the quarter ending 2013-12-31 was $0.00, a 100.00% decline year-over-year.
- BIOGEN INC. noncontrolling interest, decrease from deconsolidation for fiscal 2016 was $7.50M.
- BIOGEN INC. noncontrolling interest, decrease from deconsolidation for fiscal 2013 was $1.70M, a 205.76% increase from fiscal 2012.
- BIOGEN INC. noncontrolling interest, decrease from deconsolidation for fiscal 2012 was $556.00K.
| Period end | Noncontrolling Interest, Decrease from Deconsolidation 3 month | Noncontrolling Interest, Decrease from Deconsolidation 6 month | Noncontrolling Interest, Decrease from Deconsolidation 9 month | Noncontrolling Interest, Decrease from Deconsolidation 12 month | Noncontrolling Interest, Decrease from Deconsolidation 12 month as first filed |
|---|---|---|---|---|---|
| 2016-12-31 | $7.50M 10-K · filed 2019-02-06 | ||||
| 2014-09-30 | $0.00 10-Q · filed 2014-10-22 | $0.00 derived: sum of 2 quarters · filed 2014-10-22 | $0.00 10-Q · filed 2014-10-22 | $0.00 derived: sum of 4 quarters · filed 2016-02-03 | |
| 2014-06-30 | $0.00 10-Q · filed 2014-07-23 | $0.00 10-Q · filed 2014-07-23 | $0.00 derived: sum of 3 quarters · filed 2016-02-03 | $0.00 derived: sum of 4 quarters · filed 2016-02-03 | |
| 2014-03-31 | $0.00 10-Q · filed 2014-04-23 | $0.00 derived: sum of 2 quarters · filed 2016-02-03 | $0.00 derived: sum of 3 quarters · filed 2016-02-03 | $0.00 derived: sum of 4 quarters · filed 2016-02-03 | |
| 2013-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-03 | $0.00 derived: sum of 2 quarters · filed 2016-02-03 | $0.00 derived: sum of 3 quarters · filed 2016-02-03 | $1.70M 10-K · filed 2016-02-03 | -$1.68M 10-K · filed 2014-02-06 |
| 2013-09-30 | $0.00 10-Q · filed 2014-10-22 | $0.00 derived: sum of 2 quarters · filed 2014-10-22 | $1.70M 10-Q · filed 2014-10-22 | $1.76M derived: sum of 4 quarters · filed 2015-02-04 | |
| 2013-06-30 | $0.00 10-Q · filed 2014-07-23 | $1.70M 10-Q · filed 2014-07-23 | $1.76M derived: sum of 3 quarters · filed 2015-02-04 | $1.76M derived: sum of 4 quarters · filed 2015-02-04 | |
| 2013-03-31 | $1.70M 10-Q · filed 2014-04-23 | $1.76M derived: sum of 2 quarters · filed 2015-02-04 | $1.76M derived: sum of 3 quarters · filed 2015-02-04 | $2.26M derived: sum of 4 quarters · filed 2015-02-04 | |
| 2012-12-31 | $56.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-04 | $56.00K derived: sum of 2 quarters · filed 2015-02-04 | $556.00K derived: sum of 3 quarters · filed 2015-02-04 | $556.00K 10-K · filed 2015-02-04 | -$556.00K 10-K · filed 2013-02-05 |
| 2012-09-30 | $0.00 10-Q · filed 2013-10-28 | $500.00K derived: sum of 2 quarters · filed 2013-10-28 | $500.00K 10-Q · filed 2013-10-28 | ||
| 2012-06-30 | $500.00K 10-Q · filed 2013-07-25 | $500.00K 10-Q · filed 2013-07-25 | |||
| 2012-03-31 | $0.00 10-Q · filed 2013-04-25 | ||||
| 2011-09-30 | $0.00 10-Q · filed 2012-10-25 | $0.00 10-Q · filed 2012-10-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Revolution Medicines, Inc. (RVMD) | United States | $42.805B | -22.69 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |